ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Verve Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - VERV - Verve Therapeutics ( NASDAQ:VERV )
NEW YORK, Sept. 13, 2024 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Verve Therapeutics, Inc.
| Ticker |
Sentiment |
Impact |
|
META
|
Neutral
|
6 %
|
|
VERV
|
Somewhat Bullish
|
23 %
|
